Pomotrelvir and Nirmatrelvir Binding and Reactivity with SARS‐CoV‐2 Main Protease: Implications for Resistance Mechanisms from Computations
Open Access
- 2 September 2024
- journal article
- research article
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 63 (40) , e202409527
Abstract
We investigate the inhibition mechanism between pomotrelvir and the SARS‐CoV‐2 main protease using molecular mechanics and quantum mechanics/molecular mechanics simulations. Alchemical transformations where each Pi group of pomotrelvir was transformed into its counterpart in nirmatrelvir were performed to unravel the individual contribution of each group to the binding and reaction processes. We have shown that while a γ‐lactam ring is preferred at position P1, a δ‐lactam ring is a good alternative for the design of inhibitors for variants presenting mutations at position 166. For the P2 position, tertiary amines are preferred with respect to secondary amines. Flexible side chains at the P2 position can disrupt the preorganization of the active site, favouring the exploration of non‐reactive conformations. The substitution of the P2 group of pomotrelvir by that of nirmatrelvir resulted in a compound, named as C2, that presents a better binding free energy and a higher population of reactive conformations in the Michaelis complex. Analysis of the chemical reaction to form the covalent complex has shown a similar reaction mechanism and activation free energies for pomotrelvir, nirmatrelvir and C2. We hope that these findings could be useful to design better inhibitors to fight present and future variants of the SARS‐CoV‐2 virus.Keywords
Funding Information
- Conselleria de Cultura, Educación y Ciencia, Generalitat Valenciana (PROMETEO CIPROM/2021/079)
This publication has 17 references indexed in Scilit:
- Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19New England Journal of Medicine, 2024
- Dynamical Nonequilibrium Molecular Dynamics Simulations Identify Allosteric Sites and Positions Associated with Drug Resistance in the SARS-CoV-2 Main ProteaseJACS Au, 2023
- Design, synthesis and biological evaluation of covalent peptidomimetic 3CL protease inhibitors containing nitrile moietyBioorganic & Medicinal Chemistry, 2023
- The impact of SARS-CoV-2 3CL protease mutations on nirmatrelvir inhibitory efficiency. Computational insights into potential resistance mechanismsChemical Science, 2023
- Main protease mutants of SARS-CoV-2 variants remain susceptible to nirmatrelvirBioorganic & Medicinal Chemistry Letters, 2022
- Insights into the binding and covalent inhibition mechanism of PF-07321332 to SARS-CoV-2 MproRSC Advances, 2022
- Computational simulations on the binding and reactivity of a nitrile inhibitor of the SARS-CoV-2 main proteaseChemical Communications, 2021
- Rational Design of Hybrid SARS-CoV-2 Main Protease Inhibitors Guided by the Superimposed Cocrystal Structures with the Peptidomimetic Inhibitors GC-376, Telaprevir, and BoceprevirACS Pharmacology & Translational Science, 2021
- Unraveling the SARS-CoV-2 Main Protease Mechanism Using Multiscale MethodsACS Catalysis, 2020
- Adaptive Finite Temperature String Method in Collective VariablesThe Journal of Physical Chemistry A, 2017